Search

everythinglearnresearchcommunity

for

Search:↓

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

JAK inhibitors show promise for treating skin disorders like alopecia, eczema, and psoriasis.

Guidelines suggest various treatments for alopecia areata, but leaving it untreated is also an option as 80% cases may recover on their own.

Targeted cancer therapies often cause serious skin problems that need careful management.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

Blocking JAK-STAT signaling can lead to hair growth.

Hormones, especially androgens, play a big role in acne, but most acne sufferers don't have a hormone disorder. Hormonal treatments, including birth control pills, can be very effective for women whose acne doesn't improve with regular treatments.

Manipulating the catagen and telogen phases of hair growth could lead to treatments for hair disorders.

HGF/SF injections can stimulate hair growth and increase hair follicle size in mice.

Treating psoriasis on the scalp, nails, and skin folds is challenging, often requiring systemic treatments for severe cases, with some success in topical and biologic treatments.

A mother's PPARγ is crucial for preventing harmful milk that can cause inflammation and growth problems in babies.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Myc changes chromatin in stem cells, causing them to leave their niche.

Calcineurin inhibitors, used in kidney transplants, can cause a wide range of side effects including kidney damage and other health issues.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Hormonal treatments can help with acne, especially in women, by lowering androgen levels or blocking their effects.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Most dermatologic medications are safe during pregnancy and breastfeeding, but some should be avoided due to potential risks.

Short-chain fatty acids from *Cutibacterium acnes* cause skin inflammation, contributing to acne.

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

European guidelines recommend regular eye and ear exams, skin care, vitamin D supplements, and cautious use of medications for managing congenital ichthyoses.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.